ArticleCancers2026

Evaluation of Costs, Efficiency and Performance of a Pilot Genetic Testing Traceback Program for Ovarian Cancer.

Dina Hassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.